12:10 PM
 | 
May 08, 2017
 |  BC Innovations  |  Distillery Techniques

Drug platforms

TECHNOLOGY: Cell therapy

An in vitro differentiation protocol could generate V2a interneurons from HPSCs for use as cell therapies to treat SCI. The protocol had three steps: treating HPSCs with two tool compounds that inhibit SMAD pathway signaling for five days to enhance neural differentiation; transferring the cells to neural induction media containing retinoic acid and the two SMAD...

Read the full 266 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >